About the Peter Munk Cardiac Centre

Whatever it takes

The Peter Munk Cardiac Centre is the premier designation to treat heart diseases in Canada. We have over 163,000 out-patient visits a year and multidisciplinary teams perform more than 2,500 cardiac and vascular surgeries, 7,800 interventional cardiology procedures, 35 heart transplants, and 45 mechanical heart support implants annually. Under the leadership of Dr. Barry Rubin, Medial Director and Chair, the Peter Munk Cardiac Centre is harnessing the power of the latest research breakthroughs and technological advancements, including artificial intelligence and machine learning, to deliver the strongest patient outcomes.

The Peter Munk Cardiac Centre routinely cares for patients who would otherwise have nowhere else to turn. We treat some of the rarest and most complex cases; performing operations that other institutions have turned down. The quality of the Peter Munk Cardiac Centre team is at the heart of this success, making us a world leader in research, innovation, and patient outcomes. It is because of this that we are a sought-out destination for training in a variety of specialities.

Leading the Future of Adult Congenital Heart Disease Care
Congenital heart defects are the world’s leading birth defect, caused by a development abnormality of one or more structures of the heart and/or blood vessels. There is no cure for congenital heart disease. A patient’s heart is continually repaired, but never cured, meaning adults still need specialized, lifelong care. With more than 90% of children born with congenital heart disease now surviving into adulthood, the need for expert adult care has grown dramatically.

The Adult Congenital Heart Disease (ACHD) Program at the Peter Munk Cardiac Centre is one of the world’s first and largest programs dedicated to supporting this complex and growing population. Built on more than six decades of leadership, the program provides lifelong, compassionate care beginning at age 18, backed by unmatched clinical expertise, pioneering research, and experience caring for some of the most diverse and complex cases. The team has led the creation of international guidelines, advanced minimally invasive treatments, strengthened transitions from paediatric care, and built global educational networks. With its deep history and ongoing innovation, the ACHD Program is shaping a future where adults born with congenital heart disease can live full, vibrant lives with confidence and support at every stage.

Learn more about the Peter Munk Cardiac Centre.